Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
Apply
HCB101
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step